Placebo topical formulation

DRUG2 trials

Sponsors

Sinomune Pharmaceutical Co., Ltd, University of Guadalajara

Conditions

MelasmaTinea Pedis

Phase 1

A Phase 1b Study of ZYG24004 in Participants With Tinea Pedis Caused by Dermatophytes

RecruitingNCT07668999

Sinomune Pharmaceutical Co., LtdTinea Pedis

Start: 2026-07-21End: 2027-06-10Target: 64Updated: 2026-08-04

Unknown Phase

Efficacy and Safety of a Combined Topical Formula Versus Placebo in Patients With Melasma

CompletedNCT07727954

University of GuadalajaraMelasma

Start: 2026-06-12End: 2026-07-13Updated: 2026-07-27